This analysis assesses whether people can afford to pay cost-sharing amounts common with private insurance plans. It finds that large shares of non-elderly households do not have enough liquid assets to meet typical plan cost-sharing amounts.
Category: Kaiser Family Foundation
KFF COVID-19 Vaccine Monitor: The Pandemic’s Toll on Workers and Family Finances During the Omicron Surge
The Vaccine Monitor report examines how families and workers fared financially during the omicron surge. Large shares of workers missed work due to being sick from coronavirus, having to quarantine, or their workplace being closed due to the pandemic. …
4 in 10 Workers – and 6 in 10 of Those with Low Incomes – Say They Missed Work During the Omicron Surge Due to COVID-19 Illness, Quarantine or Closure
The surge in COVID-19 cases triggered by the omicron variant led to widespread work disruptions, with about 4 in 10 workers (42%) – including 6 in 10 of those with lower incomes – saying they had to miss work at least once in the past three months beca…
Prices Increased Faster Than Inflation for Half of all Drugs Covered by Medicare in 2020
Recent legislation would require drug companies to pay rebates to the federal government when annual increases in prescription drug prices for Medicare and private insurance exceed the rate of inflation. As context for understanding the possible impact…
How has health spending changed over time?
This slideshow examines trends in U.S. health spending over time, including the share of household budgets devoted to health expenses and comparisons of out-of-pocket expenditures to money spent on insurance through 2020, when the COVID-19 pandemic hit.
Outpatient telehealth use soared early in the COVID-19 pandemic but has since receded
Telehealth use skyrocketed during the early months of the pandemic. While it has since decreased somewhat from that high, it still represents a much more substantial share of health care than before COVID, this KFF-Epic Research analysis finds.
Reports on Health Insurance and Health Care Costs from the Kaiser Family Foundation 2022-02-10 09:17:48
This updated analysis examines COVID-19’s effect on mortality rates, and estimates that in January 2022, COVID-19 was number two on the list of leading causes of death in the U.S.
How Do Prescription Drug Costs in the United States Compare to Other Countries?
This chart collection examines what we know about prescription drug spending and use in the U.S. and comparably large and wealthy countries, using data from the Organization for Economic Cooperation and Development (OECD).
COVID-19 leading cause of death ranking
This updated analysis examines COVID-19’s effect on mortality rates, and estimates that in January 2022, COVID-19 was number two on the list of leading causes of death in the U.S.
Tracking The Pandemic’s Effects On Health Outcomes, Costs, And Access To Care
This Health Affairs Grantwatch article summarizes findings from several KFF-Peterson Health System Tracker analyses with an emphasis on the COVID-19 pandemic’s impact through 2021 and a look ahead toward 2022.
